Introduction at the special issue on implications of cancer stem/progenitor cell concepts in molecular oncology and novel targeted therapies

2014 ◽  
Vol 39 ◽  
pp. 1-2
Author(s):  
Murielle Mimeault ◽  
Surinder K. Batra
Cancers ◽  
2020 ◽  
Vol 12 (10) ◽  
pp. 3036
Author(s):  
Efisio Puxeddu ◽  
Giovanni Tallini ◽  
Roberta Vanni

The incidence of thyroid cancer has increased over the past 3 to 4 decades. Nonetheless, the mortality from thyroid cancer has remained stable. The thyroid gland may develop nodules encompassing several types of cell proliferation, from frankly benign to very aggressive forms with many intermediate challenging variants. For this reason, there is growing interest in evaluating thyroid nodules from many points of view, from the clinical to the molecular aspects, in the search for innovative diagnostic and prognostic parameters. The aim of this Special Issue was to provide an overview of recent developments in understanding the biology and molecular oncology of thyroid tumors of follicular cell derivation and their repercussions on the diagnosis, prognosis, and therapy. The contributions of many experts in the field made up a Special Issue of Cancers journal, that focusing on different aspects, including mechanistic and functional facets, gives the status of art of clinical and biological perspectives of thyroid cancer.


2021 ◽  
Vol 6 ◽  
pp. 111-117
Author(s):  
Manoj Mahajan ◽  
Nishigandha Mandawade ◽  
Randeep Singh ◽  
Purvish Parikh ◽  
Saurabh Sharma

2019 ◽  
Vol 20 (15) ◽  
pp. 3790
Author(s):  
Georg C. Hutterer

This Special Issue of International Journal of Molecular Sciences (IJMS) covers one of the most intriguing and emerging fields in terms of molecular oncology and uro-oncologic research efforts over the recent years, namely urothelial carcinoma of the bladder (UCB), as well as urothelial carcinoma of the upper urinary tract (UTUC). A total of 8 articles published in this Special Issue highlight the current progress in molecular oncology and cancer genetics in UCB, including a wide range of research topics, such as FGFR-inhibitors, sarcopenia in UCB, molecular predictors of response following neoadjuvant chemotherapy, exercise cardiac training impacts in the murine UCB model, Obatoclax, tropomyosins as potential biomarkers, immunotherapeutic approaches, as well as a transcriptional analysis of immunohistochemically defined UCB-subgroups. Find a brief summary of the respective articles below.


2020 ◽  
Vol 21 (11) ◽  
pp. 4081
Author(s):  
Carlos Martínez-Campa ◽  
Carolina Alonso-González

The Special Issue entitled “New Strategies in Cancer Pharmacotherapy: Development of Hormonal Antineoplastic Drugs, Cytotoxic Drugs and Targeted Therapies” was conceived with the idea of compiling information on the latest advances in the treatment of both hormone-dependent and hormone-independent cancers [...]


Sign in / Sign up

Export Citation Format

Share Document